Our respiratory research has long standing collaborations with industry and other research institutions.
We are part of several major national/international collaborations and work closely with commercial pharma companies and are part of the NIHR NOCRI Translational Research Collaboration (TRC) in inflammatory respiratory disease headed by Professor Tim Harrison.
The TRC brings together internationally recognised investigators in the UK’s leading centres of excellence to carry out early phase research with industry.
We are also an integral part of the Nottingham Molecular Pathology Node (NMPN) Leading the field in translational molecular diagnostic capabilities
The NMPN is one of 6 nodes funded by the Medical Research Council (MRC)and the Engineering and Physical Sciences Research Council (EPSRC) to develop molecular pathology tests which will help deliver better targeted, more effective treatments – known as ‘stratified medicine’ – across a wide range of disease areas.
We have close links on respiratory themes with researchers within other research groupings in the University of Nottingham and Nottingham University Hospitals NHS Trust, such as epidemiology, molecular microbiology, drug discovery, allergy, immunology and child health.